Thermo Fisher's PPD takes enterprise access to HealthVerity's TaXOnomy claims dataset
A short entry: a summary of the public record, checked against its sources, not yet read and analysed by Gianluca. How the register works
Thermo Fisher Scientific announced a strategic collaboration with HealthVerity under which Thermo Fisher's PPD clinical research business gains enterprise-level access to HealthVerity's TaXOnomy claims dataset covering more than 270 million de-identified US patient records. The collaboration also enables access to over 70 curated data sources including electronic medical records, laboratory data and specialty datasets.
What happened
- Digital Health News article last updated 14 August 2026.
- PPD gains enterprise-level access to HealthVerity's TaXOnomy claims dataset of more than 270 million de-identified US patient records.
- Access extends to over 70 curated data sources including electronic medical records, laboratory data and specialty datasets.
- Collaboration is intended to boost RWE and health economics and outcomes research (HEOR) capabilities across PPD CorEvitas Clinical Registries and PPD Evidera solutions.
- Krishna Cheriath, Vice President, Head of Clinical Research, Digital and AI, Biopharma Services, Thermo Fisher Scientific, commented on the partnership.
- Thermo Fisher completed its $17.4 billion acquisition of PPD on 8 December 2021.
Who is involved
Thermo Fisher Scientific is an American life science and clinical research company.
2025 annual revenue US$44.556B
HealthVerity partners with pharma, payers and government agencies to synchronize Identity, Privacy, Governance and Exchange.
Sources
- digitalhealthnews.com — primary
- google.com — party background
- drugdiscoverytrends.com — party background
- tracxn.com — party background
- healthverity.com — party background
Announced 2026-08-14